secwatch / observer
OBX Gazelle Parent, Inc.
CIK 0002130606 2 ready 8-Ks latest August 14, 2026, 4:29 PM ET RSS · JSON
Activity: ELEVATED 2 filings / 30d vs 0 baseline Risk accumulating: repeated leadership change (9)
Ready 8-Ks 2
Latest filing August 14, 2026, 4:29 PM ET
Top materiality 0.85
Event mix m_and_a ×2
Sentiment 0 pos · 0 neg · 2 neu
Executive change recent →

Recent 8-K filings for OBX

Highest-materiality recent filing

Obsidian Therapeutics completes reverse merger with Legacy Obsidian and Galera; begins trading on Nasdaq under OBX

August 3, 2026, 5:08 PM ET M&A materiality 0.85 neutral item 1.01item 2.01item 2.02item 3.02item 3.03item 4.01item 5.01item 5.02item 5.03item 7.01item 9.01 ◈ executive_change ×9

Read filing →

Executive changes

Departed

Julie Feder

Director
OBX · Gazelle Parent, Inc.
Effective
2026-08-03
Filed
August 3, 2026, 5:08 PM ET
J. Mel Sorensen, M.D. and Julie Feder resigned from the Board and committees of the Board on which they respectively served, which resignations were not the result of any disagreements with our company relating to our operations, policies or practices.
Appointed

Madan Jagasia, M.D., M.S.

Director
OBX · Gazelle Parent, Inc.
Effective
2026-08-03
Filed
August 3, 2026, 5:08 PM ET
the Board was reconstituted as follows: Peter Barrett, Ph.D., Matthew Norkunas, M.D., M.B.A., Heidi Hagen, Madan Jagasia, M.D., M.S., Maria Fardis, Ph.D., M.B.A., and Robert Ross, M.D. (each designated by Legacy Obsidian).
Appointed

Heidi Hagen

Director
OBX · Gazelle Parent, Inc.
Effective
2026-08-03
Filed
August 3, 2026, 5:08 PM ET
the Board was reconstituted as follows: Peter Barrett, Ph.D., Matthew Norkunas, M.D., M.B.A., Heidi Hagen, Madan Jagasia, M.D., M.S., Maria Fardis, Ph.D., M.B.A., and Robert Ross, M.D. (each designated by Legacy Obsidian).
Departed

J. Mel Sorensen, M.D.

Director
OBX · Gazelle Parent, Inc.
Effective
2026-08-03
Filed
August 3, 2026, 5:08 PM ET
J. Mel Sorensen, M.D. and Julie Feder resigned from the Board and committees of the Board on which they respectively served, which resignations were not the result of any disagreements with our company relating to our operations, policies or practices.
Appointed

Matthew Norkunas, M.D., M.B.A.

Director
OBX · Gazelle Parent, Inc.
Effective
2026-08-03
Filed
August 3, 2026, 5:08 PM ET
the Board was reconstituted as follows: Peter Barrett, Ph.D., Matthew Norkunas, M.D., M.B.A., Heidi Hagen, Madan Jagasia, M.D., M.S., Maria Fardis, Ph.D., M.B.A., and Robert Ross, M.D. (each designated by Legacy Obsidian).
Appointed

Maria Fardis, Ph.D., M.B.A.

Director
OBX · Gazelle Parent, Inc.
Effective
2026-08-03
Filed
August 3, 2026, 5:08 PM ET
the Board was reconstituted as follows: Peter Barrett, Ph.D., Matthew Norkunas, M.D., M.B.A., Heidi Hagen, Madan Jagasia, M.D., M.S., Maria Fardis, Ph.D., M.B.A., and Robert Ross, M.D. (each designated by Legacy Obsidian).
Appointed

Maria Fardis, Ph.D., M.B.A.

Chairperson of the Board
OBX · Gazelle Parent, Inc.
Effective
2026-08-03
Filed
August 3, 2026, 5:08 PM ET
Maria Fardis, Ph.D. was appointed Chairperson of the Board.
Appointed

Peter Barrett, Ph.D.

Director
OBX · Gazelle Parent, Inc.
Effective
2026-08-03
Filed
August 3, 2026, 5:08 PM ET
the Board was reconstituted as follows: Peter Barrett, Ph.D., Matthew Norkunas, M.D., M.B.A., Heidi Hagen, Madan Jagasia, M.D., M.S., Maria Fardis, Ph.D., M.B.A., and Robert Ross, M.D. (each designated by Legacy Obsidian).
Appointed

Robert Ross, M.D.

Director
OBX · Gazelle Parent, Inc.
Effective
2026-08-03
Filed
August 3, 2026, 5:08 PM ET
the Board was reconstituted as follows: Peter Barrett, Ph.D., Matthew Norkunas, M.D., M.B.A., Heidi Hagen, Madan Jagasia, M.D., M.S., Maria Fardis, Ph.D., M.B.A., and Robert Ross, M.D. (each designated by Legacy Obsidian).

Materiality & sentiment trend

Max materiality 0.85 · Median 0.82 · Most common event m_and_a

0 positive 0 negative 2 neutral

source · OBX on sec.gov